Healthcare Law

The scope and capabilities of the Weintraub Healthcare attorneys and Healthcare group are unique to the region and in demand nationwide. Our expertise includes managing complex healthcare mergers & acquisitions, advice on emerging provider types and treatment models, representation in a wide array of healthcare-related joint ventures, counseling on Medicare and Medi-Cal enrollment and certification matters, and guidance on the full spectrum of agreements and regulatory matters that their clients face. The lawyers in this Group bring decades of experience, technical skill, and industry knowledge to every engagement.

Weintraub healthcare attorneys are known for their expertise in business law, regulatory healthcare law, and mergers & acquisitions. Their healthcare clients reflect a broad spectrum of entities and their investors, such as health systems, medical foundations, ambulatory surgery centers (ASCs), independent practice associations (IPAs), healthcare technology companies, behavioral health providers, concierge and telehealth companies, home health providers, durable medical equipment suppliers, and private equity/venture capital investors in various healthcare niches. The attorneys in the Healthcare group often serve as general counsel/transactional counsel/healthcare regulatory counsel to startups, established businesses, or private or public consolidators of various healthcare providers. In addition to serving healthcare clients, the Weintraub healthcare lawyers are experienced merger & acquisition and transactional business attorneys.

Salem & Green merged with and into Weintraub Tobin in January 2022. Read more about the merger here.

Jeanne Vance Presents at the AHLA’s Institute on Medicare and Medicaid Payment Issues Conference in Baltimore

On March 26th, Weintraub shareholder Jeanne Vance presented Medicare Payment Models of the Center for Medicare & Medicaid Innovation for the American Health Law Association’s Institute on Medicare and Medicaid Payment Issues Conference in Baltimore, Maryland. This annual conference is a uniquely collegial opportunity for participants of a highly regulated…

  • When: Mar 26, 2025 03:00 pm PDT – 04:00 pm PDT
  • Where: Baltimore, MD

Jeanne Vance Presents on The 2024 Medicare Physician Fee Schedule for Medicare Mental Health Workforce Coalition

On August 17th, 2023, NBCC and the Medicare Mental Health Workforce Coalition will host an informative webinar titled Assessing the Essential Features of the 2024 Medicare Physician Fee Schedule Rule and Implications for Counselors and MFTs. Weintraub shareholder Jeanne L. Vance will serve as presenter. Other panelists will include Doug Jacobs, Chief…

  • When: Aug 17, 2023
  • Where: Webinar

Jeanne L. Vance Spoke At The American Health Lawyers’ Association’s Medicare Medicaid Payment Issues Conference Regarding Provider Enrollment, For The Ninth Consecutive Year

For the ninth consecutive year, Jeanne L. Vance presented at the American Health Lawyers’ Association’s Medicare Medicaid Payment Issues conference regarding provider enrollment. Ms. Vance was a panelist regarding “Hot Topics in Provider Enrollment” March 20-22, 2019 in Baltimore, Maryland.

  • When: Mar 20-22, 2019
  • Where: Baltimore, Maryland

Anders Bostrom Elected to Board of Directors for Parkinson’s Association of Northern California (PANC)

Weintraub Tobin is pleased to announce that associate Anders L. Bostrom has been elected to the Board of Directors for Parkinson’s Association of Northern California (PANC). As a corporate and healthcare attorney, Anders counsels businesses, nonprofits, and healthcare organizations across California on business transactions and transition, corporate governance, regulatory compliance…

Weintraub Tobin Welcomes Kelly K. Ross

Weintraub Tobin is pleased to welcome Kelly K. Ross as an associate in the Firm’s Corporate and Healthcare practice groups. She will be based in the Firm’s Sacramento office. Kelly brings several years of experience in the healthcare industry, specializing in contract management and regulatory filings.

Weintraub Tobin Welcomes Jon E. Ancona

Weintraub Tobin is pleased to welcome Jon E. Ancona as an associate in the Firm’s Corporate practice group. He focuses his practice on mergers and acquisitions, emerging companies and venture capital, and other corporate and securities law matters.

Weintraub Tobin Welcomes Tatum J. Kennedy

Weintraub Tobin is pleased to welcome Tatum J. Kennedy as an associate in the Firm’s Corporate practice group, with a focus on general corporate governance, entity formations, mergers and acquisitions, corporate finance, and other entity transactions.

Weintraub Tobin Welcomes Aysha Majeed

Weintraub is pleased to welcome Aysha Majeed as an associate in the Firm’s Healthcare and Corporate practice groups. Her practice focuses on serving healthcare-related clients as they navigate rules and requirements as well as agreements and other ventures.

Jeanne Vance in AHLA: Summary of Meaningful Revisions to Chapter 10 of the Medicare Program Integrity Rule Regarding Provider Enrollment Matters

In a March bulletin for the American Health Law Association Jeanne Vance writes the article entitled Summary of Meaningful Revisions to Chapter 10 of the Medicare Program Integrity Rule Regarding Provider Enrollment Matters. The bulletin is presented by the AHLA’s Regulation, Accreditation, and Payment Practice Group. It summarizes revisions made by…

WT Deals: Signature Healthcare Behavioral Health Hospital

Jeanne Vance assisted with licensing for Signature Healthcare Services as they expanded into the Sacramento region with the Sacramento Behavioral Health Hospital. The 117-bed facility is the first acute psychiatric hospital to be licensed in California in 30 years. The hospital began accepting patients in December, but it is still…

President Signs Executive Order To Study IVF Policy Protections Forecasting Possible Future Federal Safeguards for California IVF Clinics

Executive Order Signals Shift On February 18, 2025, President Donald Trump signed an executive order to study policy recommendations to protect access to in vitro fertilization (IVF) and to reduce their associated costs.[1]  While headlines about the order suggested protections for IVF, the executive order really signaled a policy intention…

Disclosure Obligations Never Cease for California Healthcare Providers: A Roundup of Recent Legal Developments

Corporate Transparency Act Updates as Compliance Deadline Looms; Longer Disclosure Period and Public Hearing Now Required for Maternity/Psych Unit Closures; and California Governor Vetoes Healthcare Transaction AG Approval Process for Private Equity Transactions As we move into the fourth quarter of 2024, there are a flurry of breaking news items…

Proposed Medicare and Medicaid Enrollment Rule for Skilled Nursing Facilities Implements Law Expanding Regulation of Private Equity Investments in Healthcare, Foreshadowing a Likely Trend

On February 13, 2023, the Centers for Medicare & Medicaid Services (“CMS”) proposed a long-delayed regulation that would implement a provider enrollment provision of the Affordable Care Act that expands the information required to be disclosed by skilled nursing facilities (“SNFs”). The law requires that SNFs report detailed information to CMS…

California Healthcare Transactions to Undergo Additional Advance Regulatory Scrutiny as New Office of Health Care Affordability Scrutinizes Cost and Market Impact of Transaction

Certain healthcare transactions closing on or after April 1, 2024 are subject to an advance notice regulatory review and analysis by a newly created Office of Health Care Affordability (“OHCA”) within the California Department of Health Care Access and Information.  The OHCA will prospectively analyze the transactions by conducting a…

Healthcare Transactions With Licensed Healthcare Professionals Trigger Corporate Practice Issues In California

This second transactions series installment involves consideration of professional licensing issues that arise in certain healthcare transactions with licensed professionals (including physicians), or so-called “corporate practice” issues. This series responds to the active transactional market for 2021 and the forecast for robust activity due to the interest of venture capital…